Consolidation of AML therapy with autograft and allograft procedures does not negate the poor prognostic impact of FLT3 internal tandem duplications: Results from the UK MRC AML 10 & 12 Trials

PD Kottaridis, RE Gale, Martin Holt, Keith Wheatley, AH Goldstone, AK Burnett, DC Linch

Research output: Contribution to conference (unpublished)Paper

Original languageEnglish
Pages75a Abs 273
Publication statusPublished - 1 Jan 2002

Cite this